The results of the American Cancer Society’s 2014-2015 Statistical Assessment of Cancer Treatment and Survivorship Data were recently published in the online edition of the journal CA Cancer J Clin. The data show that the number of cancer survivors in the U.S. currently stands at approximately 14.5 million, and that number is projected to grow by 2024 to nearly 19 million. In the U.S., cancer incidence rates have continued to decline over the last decade, and the number of cancer survivors has grown. The majority of cancer survivors (64%) live longer than five years, and 15% live longer than 20 years. Nearly half of cancer survivors (46%) are no less than 70 years of age, while 5% of cancer survivors are under 40 years of age. The age distribution of survivors varies considerably by cancer type. For example, the majority of prostate cancer survivors (62%) are age 70 and older, while less than one-third of melanoma survivors are in this age group. The assessment showed that in 2014, for men, the three most common cancers were prostate cancer (43 percent), colon cancer (9 percent), and melanoma (8 percent). The three most common cancers in the female population are breast cancer (41%), cervical cancer (8%), and colon cancer (8%). Lung cancer is the leading cause of cancer deaths and the second most common type of cancer diagnosis for both men and women, with lung cancer survivors ranking only 8th due to the very low survival rate for lung cancer. In addition to prevalence prediction assessments, the data in this report address cancer treatment patterns, survival, and information on selected cancer treatments and short- and long-term outcomes for common cancers. Sections of Cancer Treatment & Survivorship Facts & Figures also address cancer outcomes and treatment options, impairment-driven cancer recovery, palliative care, long-term survival, and health behavioral benefits, drawing on cancer survivorship resources from the American Cancer Society and other organizations.